Randomized Clinical Trial of Pain Psychology/Neuroscience and Written Disclosure for Chronic Pain

Sponsor
Wayne State University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05513274
Collaborator
The New School for Social Research (Other)
120
1
4
21
5.7

Study Details

Study Description

Brief Summary

This study is designed to determine if a brief educational program and a written emotional disclosure task can improve chronic back/neck pain-related outcomes and change pain beliefs and other processes in individuals with chronic back pain.

Individuals will be randomly assigned to an experimental condition (pain and affect neuroscience education) or a control condition (general health activities questionnaire), and then subsequently randomized to a second experimental condition (written emotional disclosure) or a control condition (writing about healthy habits).

Analyses will examine the main and interactive effects of the pain and affect neuroscience education and written emotional disclosure on improved pain-related outcomes at 1-month follow-up. Participants in both the experimental conditions are expected to show more improvement on pain severity, pain interference, psychological distress and psychological attitudes toward pain at follow-up, relative to participants in the control groups.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: PPN + WED
  • Behavioral: PPN + HHD
  • Behavioral: HBC + HHD
  • Behavioral: HBC + WED
N/A

Detailed Description

This study will recruit adults with chronic back and neck pain. Participants will be adults between the aged of 18 and 75. Participants will be excluded if they have the presence of serious disease or impairment (cancer, systemic infection, serious vision impairment), if there is clear evidence of significant structural damage likely causing their pain (eg, vertebral compression fracture); being considered for interventional spine procedures (eg, steroidal injections) or surgery; leg or arm pain more severe than back or neck pain; if they have been diagnosed with fibromyalgia, rheumatoid arthritis or have active psychosis. Participants will be allowed to engage in this study regardless of current medication use or engagement in other treatment.

Participants who are interested in participating will complete a brief online zoom interview to determine eligibility and will be provided with basic information about the study. Once eligibility has been determined, consent form and, baseline measures will be sent out and completed online.

Participants will be emailed confirming they are still interested in participating. Once they reply, they will complete baseline measures (on-line) and then be randomized 1:1 to the pain psychology and affect neuroscience education intervention or the health behavior intervention. For the pain neuroscience education, participants will complete a 15 to 20-minute on-line exercise that inquires about 5 domains: the degree of central sensitization symptoms, catastrophizing , personality factors, stressors that triggered or exacerbated the pain, and adverse childhood experiences. The health behavior control intervention participants will engage in a 15 to 20-minute on-line exercise examining their health behaviors in five domains: exercise, sleep, diet, hygiene, and social connections.

Once they have completed the first intervention participants will be randomly assigned to the written emotional disclosure task or the healthy behavior-writing task. For the written emotional disclosure task participants will be asked to write for 20 minutes about their very deepest thoughts and feelings about the most traumatic experience of their lives. There will be a 10-minute break and when they return participants will be asked to write again for 20 minutes about how you have come to understand what happened and how you have changed because of the event. The healthy behavior writing task will include writing for 20 minutes a letter to a person of their choosing describing healthy behaviors, a 10 minute break and a second 20 minute writing task describing a time when they performed a healthy behaviors.

Follow-up measures will be administered 5 weeks after the intervention. There will be clinical outcomes assessed that reflect changes in pain severity, pain-related interference and pain catastrophizing. Psychological outcomes that reflect changes in symptoms for depression, anxiety, fatigue and sleep. Finally there will be attitudinal outcomes in stigma around chronic pain and patients' attributions about the role of psychological and brain-based factors in pain and self efficacy.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
This is a 2 by 2 factorial studyThis is a 2 by 2 factorial study
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Both patient and research assistant interviewer will be blinded to condition assignment during the baseline, intervention and follow up assessment.
Primary Purpose:
Treatment
Official Title:
Heartache and Backache- An Online Intervention Addressing Emotional and Physical Pain
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pain Psychology Neuroscience (PPN)+ Written Emotional Disclosure (WED)

Pain Neuroscience Education Exercise followed by two 20 minute emotional disclosure writing tasks

Behavioral: PPN + WED
A 15 to 20-minute exercise which they examine variables in themselves that suggest that their pain is driven by central nervous system processes. Participants will then write for 20 minutes about their very deepest thoughts and feelings about the most traumatic experience of their lives. A 10-minute break followed by writing again for 20 minutes about how they have come to understand what happened and how they have changed because of the event.
Other Names:
  • Experimental
  • Active Comparator: PPN + Healthy Habits Disclosure (HHD)

    Pain Neuroscience Education Exercise (PPN) followed by two 20 minute writing tasks about healthy behaviours

    Behavioral: PPN + HHD
    This condition is a 15 to 20-minute exercise that patients complete in which they examine variables in themselves that suggest that their pain is driven by central nervous system processes in their brains. Followed by writing for 20 minutes a letter to a person of their choosing describing healthy behaviours, a 10 minute break and then a second 20 minute writing task describing a time when they performed a healthy behaviour and pain rating scales.

    Placebo Comparator: Health Behavior Control (HBC) + HHD

    Health behavior control intervention followed by two 20 minute writing tasks about healthy behaviours

    Behavioral: HBC + HHD
    This 15 to 20-minute exercise that relates to healthy behaviours. Participants are asked to examine various domains of their own health behaviour as engaged in over the past 24 hours (e.g., nutrition, sleep, exercise, hygiene, social connections). Followed by writing for 20 minutes a letter to a person of their choosing describing healthy behaviours, a 10 minute break and then a second 20 minute writing task describing a time when they performed a healthy behaviour and pain rating scales.
    Other Names:
  • Control
  • Active Comparator: HBC+WED

    Health behavior control intervention followed by two 20 minute emotional disclosure writing tasks

    Behavioral: HBC + WED
    This 15 to 20-minute exercise that relates to healthy behaviours. Participants are asked to examine various domains of their own health behaviour as engaged in over the past 24 hours (e.g., nutrition, sleep, exercise, hygiene, social connections). Participants will then write for 20 minutes about their very deepest thoughts and feelings about the most traumatic experience of their lives. A 10-minute break followed by writing again for 20 minutes about how they have come to understand what happened and how they have changed because of the event.

    Outcome Measures

    Primary Outcome Measures

    1. Brief Pain Inventory Brief Pain Inventory pain severity scale (0 - 10; higher values = greater pain severity) [Change from baseline to 5 weeks follow-up]

      Pain severity scale (0 - 10; higher values = greater pain severity)

    Secondary Outcome Measures

    1. Pain Interference [Change from baseline to 5 weeks follow-up]

      PROMIS Pain Interference - Short Form 6b

    2. Patient-Reported Outcomes Measurement Information System: Depression short form 8b [Change from baseline to 5 weeks follow-up]

      Self-reported depression

    3. Patient-Reported Outcomes Measurement Information System: Anxiety short form 8a [Change from baseline to 5 weeks follow-up]

      Self-reported anxiety

    4. Patient-Reported Outcomes Measurement Information System: Fatigue [Change from baseline to 5 weeks follow-up]

      Self reported fatigue

    5. Patient-Reported Outcomes Measurement Information System: Sleep [Change from baseline to 5 weeks follow-up]

      Self reported sleep

    6. Pain Catastrophizing Scale [Change from baseline to 5 weeks follow-up]

      Pain Catastrophizing Scale (Sullivan et al., 1995): A summed score of the 13 Catastrophizing items will be computed (0-52, higher scores indicate greater catastrophizing)

    7. Pain attributions questionnaires [Change from baseline to 5 weeks follow-up]

      The 4-item psychological attribution scale assesses patients' beliefs that their thoughts and feelings and psychological therapy impacts pain, and the 3-item brain attribution scale assesses patient's beliefs that their pain is brain-based. Higher scores indicate a greater belief that pain is a brain-related [brain attribution] and that pain is affected by thoughts, feelings, and psychological interventions [psychological attribution])

    8. Stigma Scale for Chronic Illnesses Short Form (SSCI-8) [Change from baseline to 5 weeks follow-up]

      Stigma Scale for Chronic Illnesses short form: A summed score of the 8 items will be computed (8-40m higher scored indicate greater stigma)

    9. General Self Efficacy Scale [Change from baseline to 5 weeks follow-up]

      General Self Efficacy Scale: A summed score of the 10 items, will be computed (10-40) higher scored indicate greater self efficacy

    10. Emotional approach coping scale [Change from baseline to 5 weeks follow-up]

      Emotional approach coping scale: A summed score of the 8 items, will be computed (8-32) higher scored indicate greater emotional approach coping

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • English speaking

    • Chronic musculoskeletal back or neck pain for greater than 1 year as primary symptom complaint

    • Participants living in western countries USA, UK and Australia

    • Have access to a computer or smartphone

    Exclusion Criteria:
    • Presence of serious disease or impairment (cancer, systemic infection, serious vision impairment)

    • Clear evidence of significant structural damage likely causing their pain (eg, vertebral compression fracture);

    • Being considered for interventional spine procedures (eg, steroidal injections) or surgery;

    • Leg or arm pain more severe than back or neck pain

    • Rheumatoid arthritis

    • Fibromyalgia

    • Active psychosis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The New School for Social Research Department of Psychology New York New York United States 48202

    Sponsors and Collaborators

    • Wayne State University
    • The New School for Social Research

    Investigators

    • Study Director: Mark Lumley, PhD, Wayne State University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mark A. Lumley, Distinguished Professor, Wayne State University
    ClinicalTrials.gov Identifier:
    NCT05513274
    Other Study ID Numbers:
    • The New School
    First Posted:
    Aug 24, 2022
    Last Update Posted:
    Aug 24, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 24, 2022